Practical management of tyrosine kinase inhibitor-associated side effects in GIST-Reference-Cited by-同舟云学术

Practical management of tyrosine kinase inhibitor-associated side effects in GIST

Published:2011-02 Issue:1 Volume:37 Page:75-88
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Joensuu Heikki,Trent Jonathan C.,Reichardt Peter

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference91 articles.

1. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial;Dematteo;Lancet,2009

2. Gleevec Prescribing Information. Available from: http://www.pharma.us.novartis.com/product/pi/pdf/gleevec_tabs.pdf; 2010.

3. NCCN Clinical Practice Guidelines in Oncology. Soft tissue sarcoma V1.2010.899. Available from: http://www.nccn.org/professionals/physician_gls/about.asp; 2009.

4. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT;Blanke;J Clin Oncol,2008

5. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial;Verweij;Lancet,2004

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib;Frontiers in Pharmacology;2024-07-24

2. A case-matched study of imatinib mesylate between different formulations on plasma trough concentration, adverse events, quality of life and outcomes in gastrointestinal stromal tumor patients;PLOS ONE;2024-05-14

3. Effect of functionalization on the adsorption performance of carbon nanotube as a drug delivery system for imatinib: molecular simulation study;BMC Chemistry;2024-04-27

4. Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs);2024-04-08

5. Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada;Therapeutic Advances in Medical Oncology;2024-01